查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950806

電生理消融市場：全球產業分析、規模、佔有率、成長、趨勢與預測（2025-2032）

Electrophysiology Ablation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 210 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要發現：

  • 電生理消融市場規模（2025年預測）：38.471億美元
  • 預計市場規模（2032年）：69.428億美元
  • 全球市場成長率（2025年至2032年複合年成長率）：8.8%

本報告的研究範圍：電生理消融市場

電生理消融術是一種微創、能量型手術，透過灼熱心臟內的異常電傳導路徑來治療各種心律不整。該市場涵蓋多種產品，包括射頻消融術系統、冷凍消融系統、雷射和微波消融工具以及相關耗材和配件。心臟科醫師和電生理學家利用這些技術治療心房顫動、心房撲動、心室心搏過速和其他心律不整。該市場涵蓋醫院、心臟護理中心和專科診所，在心血管疾病管理和改善患者預後方面發揮關鍵作用。

市場成長促進因素：

全球電生理消融市場的主要驅動力是心血管疾病（尤其是影響全球數百萬人的心房顫動）盛行率的不斷上升。人口老化以及高血壓、肥胖和糖尿病等生活方式相關風​​險因素導致心律不整發病率不斷攀升，從而持續催生了對有效診斷和治療方案的需求。

消融系統的技術進步，包括改進的導管設計、增強的能量傳輸機制和即時影像引導，帶來了更好的臨床療效、更短的手術時間和更低的復發率。這些進步促使電生理消融手術在全球範圍內得到更廣泛的應用。

此外，患者和醫療服務提供者對早期療育和微創治療方法益處的認知不斷提高，也是推動市場成長的因素。新興國家醫療基礎設施的擴建和電生理檢查室數量的增加，也支持了市場需求。

市場限制：

儘管前景廣闊，電生理消融市場仍面臨許多挑戰。高昂的手術費用和昂貴的設備可能會限制低收入地區的患者獲得治療，並阻礙注重成本的醫療系統採用該技術。監管壁壘和針對新型消融技術的嚴格核准流程可能會延緩市場准入和創新。

儘管與手術併發症相關的患者安全問題相對較低，但它們仍然是阻礙因素，尤其是在需要再次消融或複雜手術的情況下。此外，一些國家的保險覆蓋範圍限制也可能阻礙電生理消融手術的廣泛應用。

市場機會：

由於科技的不斷創新和臨床應用的不斷拓展，電生理消融市場蘊藏著巨大的成長機會。脈衝電場​​（PEF）消融等能源來源以及整合人工智慧（AI）和機器學習的先進標測系統有望提高手術精度並縮短手術時間，從而創造新的市場潛力。

對心臟護理設施投資的增加和混合手術室的日益普及為市場擴張提供了途徑。擴大心律不整篩檢計畫和更加重視預防心臟病學舉措，進一步增加了早期診斷和治療的機會，從而提高了電生理消融設備的使用率。

本報告解答的關鍵問題：

  • 推動全球電生理消融市場成長的關鍵因素有哪些？
  • 哪些產品類型和技術正在不同地區和醫療保健機構中得到更廣泛的應用？
  • 手術流程創新和能源來源如何影響臨床結果和市場需求？
  • 電生理消融市場的主要參與者有哪些？他們正在採取哪些策略來保持競爭力？
  • 全球電生理消融市場有哪些新興趨勢和未來機會？

目錄

第1章執行摘要

第2章 市場概覽

  • 市場範圍和定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 任務
    • 主要趨勢
  • 新冠疫情影響分析
  • 預測因子－相關性和影響

第3章 加值見解

  • 價值鏈分析
  • 產品採納與使用量分析
  • 主要市場參與者
  • 主要企業的主要促銷策略
  • 監管狀態
  • PESTLE分析
  • 波特五力分析

4. 全球電生理消融市場展望

  • 主要亮點
    • 市場規模和年成長率
    • 絕對商機
  • 市場規模分析與預測
    • 2019-2023年市場規模績效分析
    • 目前市場規模分析及預測（2024-2032年）
  • 全球電生理消融市場產品展望
    • 2019-2023年按產品分類的市場規模表現分析
    • 按產品分類的當前市場規模分析（2024-2032 年）
      • 診斷導管
      • 消融導管
      • 訪問設備
    • 產品市場吸引力分析
  • 全球電生理消融市場展望（依應用領域分類）
    • 按應用領域分類的市場規模績效分析，2019-2023 年
    • 按應用領域分類的當前市場規模分析及預測（2024-2032 年）
      • 室上性心搏過速（SVT）消融術
      • 心室性心搏過速（VT/VPC）
      • 心房顫動（心房顫動）
      • 心房撲動
      • 其他
    • 按應用領域進行市場吸引力分析
  • 全球電生理消融市場展望（依最終用戶分類）
    • 按最終用戶分類的市場規模績效分析，2019-2023 年
    • 按最終用戶分類的當前市場規模分析及預測（2024-2032 年）
      • 醫院
      • 門診手術中心
      • 專業心臟中心
      • 診所
    • 最終用戶市場吸引力分析

5. 全球電生理消融市場區域展望

  • 2019-2023年區域市場規模表現分析
  • 2024-2032年各地區目前市場規模分析
    • 北美洲
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 中東和非洲
  • 按地區分類的市場吸引力分析

6. 北美電生理消融市場展望

7. 歐洲電生理消融市場展望

8. 東亞電生理消融市場展望

9. 南亞與大洋洲電生理消融市場展望

10. 拉丁美洲電生理消融市場展望

11. 中東和非洲電生理消融市場展望

第12章 競爭格局

  • 2024年市佔率分析
  • 市場結構
    • 市場競爭格局分析
    • 競爭對手儀錶板
  • 公司簡介（詳情 - 概述、財務狀況、策略、近期發展）
    • Biosense Webster
    • Abbott Laboratories
    • MEDTRONIC PLC
    • Boston Scientific Corporation
    • CathRx Ltd
    • Biotronik SE &Co. KG.
    • Japan Lifeline Co
    • ATRICURE, INC.
    • Auris Health
    • Biomerics.
    • Others

第13章附錄

簡介目錄
Product Code: PMRREP25474

Persistence Market Research has recently released a detailed report on the global Electrophysiology Ablation Market for the forecast period 2025-2032. This comprehensive report provides an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges, offering valuable insights into the market's structure and growth prospects.

Key Insights:

  • Electrophysiology Ablation Market Size (2025E): US$ 3,847.1 Mn
  • Projected Market Value (2032F): US$ 6,942.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.8%

Scope of the Report: Electrophysiology Ablation Market

Electrophysiology (EP) ablation involves minimally invasive procedures that use energy-based techniques to treat various cardiac arrhythmias by ablating abnormal electrical pathways in the heart. The market includes a wide range of products such as radiofrequency ablation systems, cryoablation systems, laser and microwave ablation tools, and associated consumables and accessories. These technologies are used by cardiologists and electrophysiologists to treat conditions like atrial fibrillation, atrial flutter, ventricular tachycardia, and other arrhythmias. The market spans hospitals, cardiac care centers, and specialized clinics, with key applications in cardiovascular disease management and enhanced patient outcomes.

Market Growth Drivers:

The global electrophysiology ablation market is primarily driven by the increasing prevalence of cardiovascular diseases, especially atrial fibrillation, which affects millions of people worldwide. Aging populations and lifestyle-related risk factors such as hypertension, obesity, and diabetes contribute to the rising incidence of arrhythmias, creating sustained demand for effective diagnostic and therapeutic solutions.

Technological advancements in ablation systems, including improved catheter designs, enhanced energy delivery mechanisms, and real-time imaging guidance, have led to better clinical outcomes, shorter procedure times, and reduced recurrence rates. These improvements are encouraging greater adoption of electrophysiology ablation procedures globally.

Additionally, increasing awareness among patients and healthcare providers about the benefits of early intervention and minimally invasive treatment options is driving market growth. Expansion of healthcare infrastructure in emerging economies and a growing number of electrophysiology labs further support market demand.

Market Restraints:

Despite promising prospects, the electrophysiology ablation market faces several challenges. High procedural costs and expensive equipment may limit access in low-income regions and restrict adoption in cost-sensitive healthcare systems. Regulatory barriers and stringent approval processes for novel ablation technologies can delay market entry and innovation.

Patient safety concerns related to procedural complications, although relatively low, remain a restraint, especially in cases requiring repeat ablations or complex interventions. Limited reimbursement coverage in certain countries may also hinder wider adoption of electrophysiology ablation procedures.

Market Opportunities:

The electrophysiology ablation market offers significant opportunities driven by continuous innovation and expanding clinical applications. Emerging energy sources such as pulsed electric field (PEF) ablation and advanced mapping systems that integrate artificial intelligence and machine learning are poised to enhance precision and reduce procedure times, creating new market potential.

Rising investments in cardiac care facilities and the growing adoption of hybrid operating rooms provide avenues for market expansion. Increasing focus on expanding arrhythmia screening programs and preventive cardiology initiatives presents additional opportunities for early diagnosis and treatment, thereby increasing the utilization of electrophysiology ablation devices.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global electrophysiology ablation market?
  • Which product types and technologies are gaining widespread adoption across regions and healthcare settings?
  • How are procedural innovations and energy sources influencing clinical outcomes and market demand?
  • Who are the key players in the electrophysiology ablation market, and what strategies are they using to remain competitive?
  • What are the emerging trends and future opportunities in the global electrophysiology ablation market?

Competitive Intelligence and Business Strategy:

Leading companies in the electrophysiology ablation market focus on innovation, product portfolio expansion, and strategic partnerships to strengthen their competitive position. Firms are investing significantly in research and development to improve energy delivery systems, catheter precision, and integrated imaging solutions. Collaborative efforts with hospitals, research institutions, and clinical investigators help facilitate product validation and physician training programs, enhancing technology adoption.

Business strategies such as mergers and acquisitions, geographic expansion, and alliances with distributors are key approaches to increasing market presence and access to new customer segments. Emphasis on enhancing procedural efficiency, clinical support services, and post-market surveillance further differentiates leading players in the competitive landscape.

Key Companies Profiled:

  • Abbott Laboratories
  • Biosense Webster (Johnson & Johnson)
  • Boston Scientific Corporation
  • Medtronic plc
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Stryker Corporation
  • GE Healthcare
  • CathRx Ltd.
  • Acutus Medical Inc.

Key Segments Covered in Electrophysiology Ablation Market Research

By Product Type:

  • Radiofrequency (RF) Ablation Systems
  • Cryoablation Systems
  • Laser Ablation Systems
  • Microwave Ablation Systems
  • Pulsed Electric Field (PEF) Ablation Systems

By End-User:

  • Hospitals
  • Cardiac Care Centers
  • Ambulatory Surgical Centers
  • Clinics & Specialty Care Centers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Electrophysiology Ablation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Value Chain Analysis
  • 3.2. Product Adoption / Usage Analysis
  • 3.3. Key Market Players
  • 3.4. Key Promotional Strategies, By Key Players
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Electrophysiology Ablation Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2032
  • 4.3. Global Electrophysiology Ablation Market Outlook: Product
    • 4.3.1. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
    • 4.3.2. Current Market Size (US$ Mn) Analysis, By Product, 2024-2032
      • 4.3.2.1. Diagnostic Catheter
      • 4.3.2.2. Ablation Catheter
      • 4.3.2.3. Access Device
    • 4.3.3. Market Attractiveness Analysis: Product
  • 4.4. Global Electrophysiology Ablation Market Outlook: Application
    • 4.4.1. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
    • 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2032
      • 4.4.2.1. Supraventricular tachycardia (SVT) ablation
      • 4.4.2.2. Ventricular tachycardia (VT/VPC)
      • 4.4.2.3. Atrial fibrillation (AF)
      • 4.4.2.4. Atrial flutter
      • 4.4.2.5. Others
    • 4.4.3. Market Attractiveness Analysis: Application
  • 4.5. Global Electrophysiology Ablation Market Outlook: End-User
    • 4.5.1. Historical Market Size (US$ Mn) Analysis, By End-User, 2019-2023
    • 4.5.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2024-2032
      • 4.5.2.1. Hospital
      • 4.5.2.2. Ambulatory Surgical Centre
      • 4.5.2.3. Specialty Cardiac Centers
      • 4.5.2.4. Clinic
    • 4.5.3. Market Attractiveness Analysis: End-User

5. Global Electrophysiology Ablation Market Outlook: Region

  • 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 5.2. Current Market Size (US$ Mn) Analysis, by Region, 2024-2032
    • 5.2.1. North America
    • 5.2.2. Latin America
    • 5.2.3. Europe
    • 5.2.4. East Asia
    • 5.2.5. South Asia and Oceania
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Electrophysiology Ablation Market Outlook

  • 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 6.1.1. By Country
    • 6.1.2. By Product
    • 6.1.3. By Application
    • 6.1.4. By End-User
  • 6.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2024-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Current Market Size (US$ Mn) Analysis, by Product, 2024-2032
    • 6.3.1. Diagnostic Catheter
    • 6.3.2. Ablation Catheter
    • 6.3.3. Access Device
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2032
    • 6.4.1. Supraventricular tachycardia (SVT) ablation
    • 6.4.2. Ventricular tachycardia (VT/VPC)
    • 6.4.3. Atrial fibrillation (AF)
    • 6.4.4. Atrial flutter
    • 6.4.5. Others
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2024-2032
    • 6.5.1. Hospital
    • 6.5.2. Ambulatory Surgical Centre
    • 6.5.3. Specialty Cardiac Centers
    • 6.5.4. Clinic
  • 6.6. Market Attractiveness Analysis

7. Europe Electrophysiology Ablation Market Outlook

  • 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.1.1. By Country
    • 7.1.2. By Product
    • 7.1.3. By Application
    • 7.1.4. By End-User
  • 7.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2024-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Current Market Size (US$ Mn) Analysis, by Product, 2024-2032
    • 7.3.1. Diagnostic Catheter
    • 7.3.2. Ablation Catheter
    • 7.3.3. Access Device
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2032
    • 7.4.1. Supraventricular tachycardia (SVT) ablation
    • 7.4.2. Ventricular tachycardia (VT/VPC)
    • 7.4.3. Atrial fibrillation (AF)
    • 7.4.4. Atrial flutter
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2024-2032
    • 7.5.1. Hospital
    • 7.5.2. Ambulatory Surgical Centre
    • 7.5.3. Specialty Cardiac Centers
    • 7.5.4. Clinic
  • 7.6. Market Attractiveness Analysis

8. East Asia Electrophysiology Ablation Market Outlook

  • 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.1.1. By Country
    • 8.1.2. By Product
    • 8.1.3. By Application
    • 8.1.4. By End-User
  • 8.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2024-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Current Market Size (US$ Mn) Analysis, by Product, 2024-2032
    • 8.3.1. Diagnostic Catheter
    • 8.3.2. Ablation Catheter
    • 8.3.3. Access Device
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2032
    • 8.4.1. Supraventricular tachycardia (SVT) ablation
    • 8.4.2. Ventricular tachycardia (VT/VPC)
    • 8.4.3. Atrial fibrillation (AF)
    • 8.4.4. Atrial flutter
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2024-2032
    • 8.5.1. Hospital
    • 8.5.2. Ambulatory Surgical Centre
    • 8.5.3. Specialty Cardiac Centers
    • 8.5.4. Clinic
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Electrophysiology Ablation Market Outlook

  • 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.1.1. By Country
    • 9.1.2. By Product
    • 9.1.3. By Application
    • 9.1.4. By End-User
  • 9.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2024-2032
    • 9.2.1. India
    • 9.2.2. Indonesia
    • 9.2.3. Thailand
    • 9.2.4. Singapore
    • 9.2.5. ANZ
    • 9.2.6. Rest of South Asia & Oceania
  • 9.3. Current Market Size (US$ Mn) Analysis, by Product, 2024-2032
    • 9.3.1. Diagnostic Catheter
    • 9.3.2. Ablation Catheter
    • 9.3.3. Access Device
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2032
    • 9.4.1. Supraventricular tachycardia (SVT) ablation
    • 9.4.2. Ventricular tachycardia (VT/VPC)
    • 9.4.3. Atrial fibrillation (AF)
    • 9.4.4. Atrial flutter
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2024-2032
    • 9.5.1. Hospital
    • 9.5.2. Ambulatory Surgical Centre
    • 9.5.3. Specialty Cardiac Centers
    • 9.5.4. Clinic
  • 9.6. Market Attractiveness Analysis

10. Latin America Electrophysiology Ablation Market Outlook

  • 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.1.1. By Country
    • 10.1.2. By Product
    • 10.1.3. By Application
    • 10.1.4. By End-User
  • 10.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2024-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Current Market Size (US$ Mn) Analysis, by Product, 2024-2032
    • 10.3.1. Diagnostic Catheter
    • 10.3.2. Ablation Catheter
    • 10.3.3. Access Device
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2032
    • 10.4.1. Supraventricular tachycardia (SVT) ablation
    • 10.4.2. Ventricular tachycardia (VT/VPC)
    • 10.4.3. Atrial fibrillation (AF)
    • 10.4.4. Atrial flutter
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2024-2032
    • 10.5.1. Hospital
    • 10.5.2. Ambulatory Surgical Centre
    • 10.5.3. Specialty Cardiac Centers
    • 10.5.4. Clinic
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Electrophysiology Ablation Market Outlook

  • 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.1.1. By Country
    • 11.1.2. By Product
    • 11.1.3. By Application
    • 11.1.4. By End-User
  • 11.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2024-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Current Market Size (US$ Mn) Analysis, by Product, 2024-2032
    • 11.3.1. Diagnostic Catheter
    • 11.3.2. Ablation Catheter
    • 11.3.3. Access Device
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2032
    • 11.4.1. Supraventricular tachycardia (SVT) ablation
    • 11.4.2. Ventricular tachycardia (VT/VPC)
    • 11.4.3. Atrial fibrillation (AF)
    • 11.4.4. Atrial flutter
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2024-2032
    • 11.5.1. Hospital
    • 11.5.2. Ambulatory Surgical Centre
    • 11.5.3. Specialty Cardiac Centers
    • 11.5.4. Clinic
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Biosense Webster
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Sources
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abbott Laboratories
    • 12.3.3. MEDTRONIC PLC
    • 12.3.4. Boston Scientific Corporation
    • 12.3.5. CathRx Ltd
    • 12.3.6. Biotronik SE & Co. KG.
    • 12.3.7. Japan Lifeline Co
    • 12.3.8. ATRICURE, INC.
    • 12.3.9. Auris Health
    • 12.3.10. Biomerics.
    • 12.3.11. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations